Contents Pages by Subject

Big Pharma

Article Image

https://www.lewrockwell.com by Jeremy Loffredo

Comedian and political commentator Jimmy Dore discusses a video by John Campbell, Ph.D. where he explains the similarities between Pfizer's expensive new antiviral drug for COVID and ivermectin, and why ivermectin is better.

Article Image

childrenshealthdefense.org, By Jeremy Loffredo

Comedian and political commentator Jimmy Dore discusses a video by John Campbell, Ph.D. where he explains the similarities between Pfizer's expensive new antiviral drug for COVID and ivermectin, and why ivermectin is better.

Article Image

unlimitedhangout.com, byWhitney Webb

COVID-19 erased the regulatory and trial-related hurdles that Moderna could never surmount before. Yet, how did Moderna know that COVID-19 would create those conditions months before anyone else, and why did they later claim that their vaccine being

Article Image

https://www.zerohedge.com by Whitney Webb

COVID-19 erased the regulatory and trial-related hurdles that Moderna could never surmount before. Yet, how did Moderna know that COVID-19 would create those conditions months before anyone else, and why did they later claim that their vaccine being

Article Image

mercola.com, Analysis by Dr. Joseph Mercola

One paper compared Merck's data on molnupiravir against peer-reviewed data on ivermectin and found ivermectin has a low side effect profile, costs less than molnupiravir and is more effective against SARS-CoV-2

Article Image

https://www.lewrockwell.com by Bill Sardi

Big Pharma will earn billions in profits this 2nd pandemic year; projected to be $16 billion for Moderna this year 2021 and $38.7 billion in 2022, as a startup vaccine maker. Pfizer's RNA vaccine is expected to $54.5 billion in 2022, says the drug

Anarchapulco 2024